For biological processes, lung cancer may affect transforming growth factor beta-activated receptor activity, insulin receptor substrate binding, semaphorin receptor activity, MAP kinase activity, cytoskeletal adaptor activity, misfolded protein binding, lysophosphatidic acid receptor activity, SUMO ligase activity, ubiquitin-protein ligase activity, and transcription coactivator activity. This evidence concerns the gene INSR and lung carcinoma.